• Subscribe Now
  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Skip to content
  • Subscriber Login
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube
Ganjapreneur

Ganjapreneur

Cannabis Business Information Since 2014

  • Cannabis News
    • Business News
    • Adult Use
    • Medical
    • Policy & Legislation
    • Hemp & CBD
    • International
  • Insights
    • Featured Announcements
    • Q&A Interviews
    • Podcasts
    • Vocabulary
  • Resources
    • Service Providers
    • Cannabis Brands
    • Dispensaries
    • Upcoming Events
  • Connect
    • Become a Subscriber
    • About Ganjapreneur
    • Contact Us
    • Partner With Us
    • Submit an Announcement
  • Subscribe Now
  • News Categories
  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD
Home //
Epilepsy

Epilepsy is a neurological disorder associated with abnormal electrical activity in the brain. The disorder can bring on loss of consciousness, convulsions, or episodes of sensory disturbance. Cannabis research has shown that the plant may help alleviate some of these symptoms, these articles explain more on that topic:


Georgia Parents Treating Son’s Epilepsy with Cannabis Lose Custody of Child

Medical CannabisNews Briefs
by Graham AbbottJune 1, 2018July 3, 2025

Texas Dispensary Delivers State’s First MMJ Product to 6-year-old Patient

Cannabis Industry NewsMedical CannabisNews Briefs
by TG BranfaltFebruary 2, 2018July 3, 2025
Close-up view of a medical cannabis plant's cola and sugar leaves.

CBD Seizure Drug Considered Effective Following FDA-Recognized Trials

Marijuana News BriefsMedical CannabisNews BriefsScience & Research
by TG BranfaltMay 26, 2017July 3, 2025
The capitol building of Indiana

Bill Permitting CBD Use for Epilepsy Passes Indiana Senate, Moves to House

Marijuana News BriefsMedical CannabisNews Briefs
by TG BranfaltFebruary 15, 2017July 3, 2025
An indoor cannabis grow facility in Washington state.

Cannabis Seizure Drug Shows Success in Latest U.S. Trials

Cannabis Industry NewsInternational Cannabis NewsMarijuana News BriefsNews BriefsScience & Research
by Graham AbbottSeptember 26, 2016July 3, 2025

GW Pharmaceuticals Hopes to Raise $252 Million in Public Offering

Cannabis Industry NewsInternational Cannabis NewsMarijuana News BriefsMedical CannabisNews Briefs
by Graham AbbottJuly 13, 2016July 3, 2025

Idaho Begins CBD Trial Program for Children With Epilepsy

Marijuana News BriefsMedical CannabisNews BriefsScience & Research
by Graham AbbottJanuary 19, 2016July 3, 2025

Delaware Chambers Unanimously Approve Bill Legalizing MMJ for Children with Epilepsy

Cannabis PolicyMarijuana News BriefsMedical CannabisNews Briefs
by Graham AbbottJune 16, 2015

Texas Legalizes MMJ Oils for Treatment of Epilepsy

Cannabis PolicyMarijuana News BriefsMedical CannabisNews Briefs
by Graham AbbottJune 3, 2015

Posts pagination

Newer posts 1 2 3

Featured Subscriber:

Ganjapreneur is made possible by our business subscribers. Subscribe today

Cannabis News

  • Latest News
  • Business
  • Policy & Legislation
  • Medical Cannabis
  • Adult Use
  • Hemp & CBD

Insights

  • Podcasts
  • Q&A Interviews
  • Featured Announcements
  • Science & Research
  • Vocabulary

Resources

  • Services & Equipment
  • Cannabis Brands
  • Dispensaries
  • Upcoming Events

US Markets

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Iowa
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Kansas
  • Kentucky
  • Louisiana
  • Maine
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Mississippi
  • Missouri
  • Montana
  • Nebraska
  • Nevada
  • New Hampshire
  • New Jersey
  • New Mexico
  • New York
  • North Carolina
  • North Dakota
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Vermont
  • Virginia
  • Washington
  • Washington DC
  • West Virginia
  • Wisconsin
  • Wyoming

International

  • View All
  • Amsterdam
  • Asia
  • Argentina
  • Australia
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • Guam
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Morocco
  • New Zealand
  • Puerto Rico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Thailand
  • Ukraine
  • Uruguay

Ganjapreneur

Grassroots cannabis business intelligence.

  • About us
  • Contact us
  • Become a subscriber
  • Partner with us
© 2025 Ganjapreneur Site by Bluedream
  • Facebook Page
  • Twitter
  • Instagram
  • Linkedin
  • YouTube

All rights reserved. // Terms of Use // Advertising Policy // Privacy Policy


DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.